Karl Frontzek
Impact in
- Neurology top 5%
- Long-Term Effects of COVID-19
- Neurological diseases and metabolism
-
- COVID-19 Clinical Research Studies
Papers in
-
- Prion Diseases and Protein Misfolding 11
-
- Neurological diseases and metabolism 3
- Autoimmune Neurological Disorders and Treatments 2
- Co-authors
- Adriano Aguzzi (14 shared papers)Asvin KK Lakkaraju (2 shared papers)Elisabeth J. Rushing (7 shared papers)Herbert Budka (2 shared papers)Gábor G. Kovács (1 shared paper)Mirjam I. Lutz (1 shared paper)Peter Steiger (3 shared papers)Manuel Koch (1 shared paper)
- Journals
- EMBO Molecular Medicine (3 papers)Neurology (2 papers)PLoS ONE (2 papers)Brain Pathology (2 papers)PLoS Pathogens (2 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Karl Frontzek
27 papers receiving 776 citations
Peers
Comparison fields: 5 of 80
- Neurology 249
- Neurology 136
- Infectious Diseases 94
- Genetics 47
- Virology 21
Countries citing papers authored by Karl Frontzek
This map shows the geographic impact of Karl Frontzek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Frontzek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Frontzek more than expected).
Fields of papers citing papers by Karl Frontzek
This network shows the impact of papers produced by Karl Frontzek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Frontzek. The network helps show where Karl Frontzek may publish in the future.
Co-authors
The 25 scholars most cited alongside Karl Frontzek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 86 | |
| 2 | 2020 | 79 | |
| 3 | 2016 | 76 | |
| 4 | 2020 | 72 | |
| 5 | 2013 | 71 | |
| 6 | 2010 | 70 | |
| 7 | 2017 | 58 | |
| 8 | 2017 | 31 | |
| 9 | 2019 | 26 | |
| 10 | 2021 | 26 | |
| 11 | 2021 | 25 | |
| 12 | 2022 | 19 | |
| 13 | 2014 | 16 | |
| 14 | 2016 | 16 | |
| 15 | 2018 | 16 | |
| 16 | 2018 | 16 | |
| 17 | 2020 | 15 | |
| 18 | 2020 | 11 | |
| 19 | 2019 | 11 | |
| 20 | 2023 | 10 |
About Karl Frontzek
Karl Frontzek is a scholar working on Molecular Biology, Neurology, Neurology, Cellular and Molecular Neuroscience and Oncology, having authored 31 papers that have together received 784 indexed citations. Recurring topics across this work include Prion Diseases and Protein Misfolding (11 papers), Trace Elements in Health (3 papers), Neurological diseases and metabolism (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Bone Tumor Diagnosis and Treatments (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cell Image Analysis Techniques (2 papers) and Autoimmune Neurological Disorders and Treatments (2 papers). The work is most often cited by research in Neurology (249 citations), Neurology (136 citations), Infectious Diseases (94 citations), Genetics (47 citations) and Virology (21 citations). Karl Frontzek has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Adriano Aguzzi, Asvin KK Lakkaraju, Elisabeth J. Rushing, Herbert Budka, Gábor G. Kovács, Mirjam I. Lutz, Peter Steiger, Manuel Koch, Günter Emons and Carsten Gründker. Their work appears in journals such as EMBO Molecular Medicine, Neurology, PLoS ONE, Brain Pathology and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.